Alterity Therapeutics (ATHE) announced that data from the ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy ...
US airlines are poised for moderate earnings, with expectations for Q3 2025 looking considerably weaker than Q3 2024. Read ...
By staying fluent in how asset managers deploy AI, financial advisors can enhance due diligence, safeguard fiduciary duty and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback